Hongjun Jin Selected Research

Glioblastoma (Glioblastoma Multiforme)

1/2022

A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongjun Jin Research Topics

Disease

16	Neoplasms (Cancer) 04/2024 - 08/2011
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 01/2016
6	Leukemia 01/2019 - 01/2016
4	Neuroinflammatory Diseases 01/2023 - 05/2017
4	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 02/2016
4	Infections 11/2022 - 02/2010
4	Inflammation (Inflammations) 01/2018 - 02/2012
3	Parkinson Disease (Parkinson's Disease) 01/2023 - 02/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2022 - 02/2016
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
3	Dementia (Dementias) 01/2018 - 04/2015
3	Multiple Sclerosis 01/2018 - 10/2016
3	Breast Neoplasms (Breast Cancer) 01/2013 - 11/2009
2	Nasopharyngeal Carcinoma 04/2024 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 01/2019
2	Esophageal Squamous Cell Carcinoma 07/2021 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2020
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 05/2017
2	Carcinoma (Carcinomatosis) 08/2013 - 08/2011
1	Ankylosing Spondylitis 10/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Obesity 01/2023
1	Multiple Pulmonary Nodules 01/2022
1	COVID-19 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Severe Acute Respiratory Syndrome 01/2021
1	Triple Negative Breast Neoplasms 09/2020
1	Phototoxic Dermatitis (Phototoxicity) 09/2020
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Tauopathies 02/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Atherosclerotic Plaque (Atheroma) 01/2018
1	Atherosclerosis 01/2018
1	Hyperplasia 01/2017
1	Vascular System Injuries 01/2017
1	Neointima 01/2017
1	Central Nervous System Diseases (CNS Diseases) 08/2015
1	Asthma (Bronchial Asthma) 01/2014

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 09/2021 - 11/2009
8	Proteins (Proteins, Gene)FDA Link 09/2021 - 11/2009
7	NucleophosminIBA 01/2019 - 01/2016
5	Purinergic P2X7 ReceptorsIBA 10/2023 - 05/2017
5	Sphingosine-1-Phosphate ReceptorsIBA 01/2018 - 08/2015
5	Cholinergic Agents (Cholinergics)IBA 01/2018 - 04/2015
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 01/2020
3	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 04/2024 - 01/2021
3	Small Interfering RNA (siRNA)IBA 01/2019 - 08/2011
3	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 01/2018 - 04/2015
2	N- (2- chloro- 3- (trifluoromethyl)benzyl)- N- methyl- 5- oxopyrrolidine- 2- carboxamideIBA 10/2023 - 05/2017
2	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2023 - 01/2023
2	LipopolysaccharidesIBA 12/2022 - 05/2017
2	salicylhydroxamic acid (SHAM)IBA 12/2022 - 05/2017
2	EnzymesIBA 01/2019 - 01/2014
2	Blood Proteins (Serum Proteins)IBA 01/2013 - 09/2011
1	ApoferritinsIBA 04/2024
1	Transferrin Receptors (Transferrin Receptor)IBA 04/2024
1	Mitochondrial Uncoupling ProteinsIBA 01/2023
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2023
1	Ion Channels (Ion Channel)IBA 11/2022
1	Adenosine Triphosphate (ATP)IBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Peptides (Polypeptides)IBA 09/2021
1	LY2510924IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	CXC ChemokinesIBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 09/2020
1	Metformin (Glucophage)FDA LinkGeneric 09/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2020
1	AcidsIBA 09/2020
1	heme aIBA 09/2020
1	Oxygen (Dioxygen)IBA 09/2020
1	Protein Kinases (Protein Kinase)IBA 09/2020
1	Long Noncoding RNAIBA 01/2020
1	NucleotidesIBA 01/2020
1	CPG-oligonucleotideIBA 10/2019
1	IsoenzymesIBA 01/2019
1	Pyruvate KinaseIBA 01/2019
1	VimentinIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 11/2018
1	TZ6019IBA 02/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	phosphatidylinositol-3,4-bisphosphate 4-phosphataseIBA 01/2018
1	ElementsIBA 05/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	ImmunosorbentsIBA 01/2014
1	mepolizumabIBA 01/2014
1	Chemokine CCL5IBA 01/2014

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
1	Boron Neutron Capture Therapy 01/2022
1	Radiotherapy 01/2022
1	Neoadjuvant Therapy 01/2021
1	Photochemotherapy (Photodynamic Therapy) 09/2020
1	Intravenous Injections 11/2018
1	Induction Chemotherapy 01/2016